MyMD Pharmaceuticals Inc

NASDAQ: MYMD    
Share price (5/3/24): $3.25    
Market cap (5/3/24): $7.012 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 10-K 11 pages Description of Securities Registered Pursuant to Section 12 of the Securities Exhange Act of 1934
12/34/56
EX-4.1
from 10-K 11 pages Description of Securities Registered Pursuant to Section 12 of the Securities Exhange Act of 1934
12/34/56
EX-4.1
from 8-K 31 pages Form of Warrant MyMD Pharmaceuticals, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 10-Q 17 pages Common Stock Purchase Warrant MyMD Pharmaceuticals, Inc
12/34/56
EX-4.12
from 10-K 18 pages Placement Agent Common Stock Purchase Warrant Akers Biosciences, Inc
12/34/56
EX-4.1
from 10-K 9 pages Description of Securities Registered Pursuant to Section 12 of the Securities Exhange Act of 1934
12/34/56
EX-4.19
from S-4/A 4 pages Amendment No. 1 to Rights Agreement
12/34/56
EX-4.1
from 10-K 9 pages Description of Securities Registered Pursuant to Section 12 of the Securities Exhange Act of 1934
12/34/56
EX-4.1
from 8-K 17 pages Form of Common Stock Purchase Warrant Akers Biosciences, Inc
12/34/56
EX-4.2
from 8-K 17 pages Common Stock Purchase Warrant Akers Biosciences, Inc
12/34/56
EX-4.1
from 8-K 18 pages Prefunded Common Stock Purchase Warrant Akers Biosciences, Inc
12/34/56
EX-4.1
from 8-K 62 pages Akers Biosciences, Inc. and Vstock Transfer, LLC Rights Agent Rights Agreement Dated as of September 9, 2020
12/34/56
EX-4.1
from 8-K 18 pages Placement Agent Common Stock Purchase Warrant Akers Biosciences, Inc
12/34/56
EX-4.1
from S-3 12 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Akers Biosciences, Inc. Series D Convertible Preferred Stock Pursuant to Section 14a:9-2 (4) and 14a:9-4 (3) of the New Jersey Business Corporation Act
12/34/56
EX-4.1
from 8-K 16 pages Placement Agent Common Stock Purchase Warrant Akers Biosciences, Inc
12/34/56
EX-4.1
from 8-K 18 pages Placement Agent Common Stock Purchase Warrant Akers Biosciences, Inc
12/34/56
EX-4.12
from 10-K 6 pages Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.11
from S-1/A 20 pages Placement Agent Common Stock Purchase Warrant Akers Biosciences, Inc
12/34/56
EX-4.10
from S-1/A 19 pages Pre-Funded Common Stock Purchase Warrant Akers Biosciences, Inc
12/34/56
EX-4.9
from S-1/A 17 pages Series a Convertible Preferred Stock Purchase Warrant Akers Biosciences, Inc
12/34/56